Âé¶¹´«Ã½

Equity Capital Markets

CytomX Therapeutics Inc.

05/25
|
$100.0 Million
cytomx
Âé¶¹´«Ã½ served as bookrunner for CytomX Therapeutics Inc. on its RD
Sub-Type
Registered Direct
Sector

Sub-Sector
Biopharma